Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Eli Lilly Nederland
Woman and Man Max 99 years
Eli Lilly Nederland
Update Il y a 4 ans
Comparing Problem Solving Treatment combined with duloxetine with Problem Solving Treatment alone for patients with major depressive disorder in primary care
The primary objective is assessing the depressive symptom reduction rate of mono-treatment (PST) compared to combined treatment (PST and duloxetine) in patients with major depressive disorder. In othe...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Eli Lilly Nederland
Update Il y a 4 ans
Effectiveness of the treatment of depressive disorder and comorbid pain symptoms
To establish effectiveness on severity of depression (measured by PHQ-9), of a closely monitored integrated intervention (TCCCL + duloxetine) for concomitant (sub)chronic pain and depression compared ...
Country
None
organs
None
Specialty
None
unknown
More information
Man Max 99 years
Eli Lilly Nederland B.V. (Netherlands)
Update Il y a 4 ans
Pioglitazone Influence of triglyceRide Accumulation in the Myocardium In Diabetes
Not provided at time of registration
Country
Netherlands
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Eli Lilly Nederland
Update Il y a 4 ans
An Open Label Pilot Study of Atomoxetine Hydrochloride in Adolescents with Attentioin-Deficit/Hyperactivity Disorder and Comorbid Cannabis Abuse
The primary objective of this study is to test the hypothesis that atomoxetine given at a dose of 1.2 mg/kg/day (once daily) for 12 weeks reduces symptoms of Attention-Deficit/Hyperactivity Disorder (...
Country
None
organs
None
Specialty
None
Closed trial
More information